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Introduction
The questions posedl to the panel focuse(d mainly on
methocls of exposing experimental animals andl on the
der matologic consequences of chr omium exposure. The
role of bioavailability figured prominently in both is-
sues. Individuals whose homes or workplaces are on
former chromium-waste dlumpsites an( lparticularly
children who play on such sites are likely to have skin
contact with chromium compoun(ls. If they ar e expose(l
at all it would be to a relatively low (lose, but exposure
is likely to be recurrient, and the skin may be the main
route of exposure. For childrlen, howvever, ingestion
cannot be ignor ed.
Intestinal Dosing and Bioavailability
Various approaches have been usedl to expose exlperi-
mental animals to chromium. With espect to intestinal
absorption of chromate, questions were raised regard-
ing the choice of vehicle. C. Witmer (Rutgers Univer-
sity) noted that in her studies she usedl water as the
vehicle for the so(lium salt because it was soluble andl
used corn oil for the less soluble calcium chromate andl
for prepar ing a soil slurry. She noted that esear cher s
need to take into account the impact ofdifferent solvent
conditions as well as the pH of the mixtur e relative to
intestinal pH in (lesigning such expeeriments.
With respect to the choice of gavage over feeding,
Witmer added that fee(ling experiments with ioodents
are complicated. Animals do not eat in a way that allows
delivery of a quantitative dose. They spill food and wa-
ter, and higher (loses of chromium depress feeding,
thereby affecting the actual doses deliver ed. It is most
desirable to develop a pair-feeding study, ideally using
metabolic cages.
Moderator: Michael Gochfeld. Panelists: Robert Bagdlon, Peter
Lees, Roy Albert, and (harlotte Witmer. Particilpants firom au(lience:
RobertAdams, Leslie Bidstr ul, Rober t Hazein, Paul Lioy, Ron Corcory,
Barbar-a Ger wel, and Fred Kauffman.
Environmental and Community Medicine, UMDNJ-Robert Wood
Johnson Medical School, Piscataway, NJ 08854.
Absorption is a critical elemnent in exlosure. In re-
sponse to a (uestion on absorption, Witmer note(I that
the animals were given the (loses in the morning wAhen
they p)robably ha(l an emltv stomachl an(l that absor-p-
tionl firom a full stomachnal wouldl probably be (lifferent.
F. Kauffman iaise(d the more general question about
N-hether Ne can really say anything about the actual
public healthl magnitu(le of the problem associatedl xvith
chromium contaminated soil.
P. Lees (School of Hygiene andl Public Health, Johns
Hopkins University) iespon(le(l fiom an indlustrial hy-
giene perspective, noting that it is essential to under-
stani(l the exposure of the lpopulation. Taking Jersey
City as an examl)le, he note(d that the fact that the
chemicals are present is only the first step. The system-
atic stu(lies on exposure, ultake, and bioavailability have
yet to be ma(le in Jersey City or elsewhere. It is essen-
tial to characterize the concentrations in (lust an(l to
know the pr-oporotion that is on respirable particles. This
wouldl provide information on the contribution of inha-
lation to risk. However, it is even more difficult to figure
out what is ingestedl or absorbedl through the skin, and
he concludedl that dleveloping improved measures ofex-
posure is a high priority.
Questions were raised regar(ling the aclequacy of the
epidlemiologic dlata base. L. Bidstrup summarized re-
cent studies of chromate-exposed workers in Europe
which show only a slightly elevated lung cancer risk at
current exposure levels. In her long-term study, the
excess lung cancer risk has declined fiom 3.6 times
background in the days before process changes were
made that rieduced exposure, to only about 2.0-fold ex-
cess today.
R. Albert (University of Cincinnati) noted that the
earlier chromate cohorts showed much higher relative
risks. He cited a Mancuso study (1) where measure-
ments wer-e made which allow risk estimates in terms
of a Q1* (cancer potency) value. He concurred that the
exposure assessment remains the major unknown area.
He noted that it would be no surprise ifthe level ofrisk
in more recent studies were lower, and he observed
that in the recent study reported by Bidstrup, a majorPANEL DISCUSSION
source ofhazard-the use oflime-had been eliminated.
Lime in the process leads to formation of the partially
soluble calcium chromate salt, which has a high cancer
potency.
M. Gochfeld (UMDNJ-Robert Wood Johnson Medical
School) suggested that the use of calcium chromate in
some animal studies and soluble chromates in other
studies may account for difficulties ofshowing lung can-
cer in animals. Studies using calcium chromate were
positive.
Gochfeld indicated that even within the chromate
production industry, companies differed with respect to
their actual manufacturing processes and their invest-
ment in safety and cleanliness. All of these would be
expected to change over time. So it should not surprise
anyone that the earlier studies would have the higher
relative risk. Future studies should determine whether
the chromate cohorts experience reduced risk, the fur-
ther removed they are from exposure, much as occurs
with former smokers whose lung cancer risk approaches
that ofnew smokers after about 15 years since smoking
cessation.
There remains, however, a discrepancy between the
U.S. studies which showed standardized mortality ra-
tios (SMR) for respiratory cancer in excess of 20 and
Bidstrup's studies in Britain where the SMR was not
more than 4.
Chromium Sensitivity in Industrial
Cohorts
R. Adams, author ofa major textbook on occupational
dermatology, pointed out that much of what we know
about the dermal effects ofchromium comes from stud-
ies of industrial groups, particularly those engaged in
manufacturing cement. These workers are exposed to
chromium, but also experience significant skin irritation
from the cement itself. This irritation potentiates the
effects of chromium and appears to increase the likeli-
hood ofsensitization.
Gochfeld remarked that there are two components to
understanding reactivity ofthe population ofchromium.
First, given that all members of a population are ex-
posed to a high level of chromium (for example, soil
concentration of 1000 ppm), what percentage will be-
come sensitized? Secondly, assuming that you have a
subpopulation in which all persons are sensitized, how
many will show apositive reaction to a particular dose-
or what is the dose-response curve for skin reactivity?
The problem with chromate, Adams noted, is the same
as the problem with formaldehyde and other contact
allergens. Everybody's skin is different with respect to
texture and reactivity. Its hard for novices to distin-
guish an irritant reaction from an allergic reaction.
Adams reported that there is less contact sensitivity to
chromium today than 20 years ago because less chro-
mium is used at this time, and he remarked that many
ofthe early responses were probably irritant reactions.
Adams noted that based on data from referral clinics
which see patients who already have some kind of
dermatitis, about 2.6% test positive to chromium. He
presumes that this is much higher than the proportion
in the general population, which he suspected would be
less than 0.1%, but he noted that we clearly need to
collect this data. From years of experience in patch
testing many patients with chromium, about 1 to 2%
test positive, which compares pretty favorably with
other contact allergens.
Albert asked what proportion of workers develop
chrome dermatitis. Adams suggested that it is a very
small percentage, probably about 1% or less. He noted
that cement workers have years of irritant dermatitis,
yet sometimes it takes 20 to 30 years to become sensi-
tive to chromium despite the dermatitis. Adams ac-
knowledged that there is only a small level of chro-
mium in cements (about 0.2%), but even at that low
level, with an irritant dermatitis there is a risk of get-
ting sensitized. Overall, the studies of cement workers
indicate that 8 to 9% are allergic to chromium on patch
testing but have not history ofdermatitis.
Gochfeld reiterated that the self-selection phenom-
enon probably means that those workers who became
sensitized more easily or responded more strongly re-
moved themselves from exposure by choosing other
work and therefore would not have been seen in the
clinical setting, and Adams concurred that this could
well have been the case in his cohort.
History of Patch Testing
Adams agreed that we need to know a great deal
more about chromium. He noted that historically, patch
testing was first performed around the turn ofthe cen-
tury, while in the U.S. the first skin test for chromium
was applied in 1925. The first patient tested was a blue-
print operator who developed a severe dermatitis from
contact with the blueprint solution, which happened to
be potassium dichromate. The patient was tested with
a 0.5% chromate solution, and there was a strong posi-
tive reaction. Adams pointed out that epicutaneous or
patch testing is still the main standby for determining
delayed skin hypersensitivity or type IV sensitivity.
Improved Approaches to Testing
R. Bagdon (UMDNJ-Robert Wood Johnson Medical
School) emphasized that it is desirable to improve the
standard patch testing procedure so that it can be ap-
plied in a prognostic fashion to determine whether a
community population is prone to becoming or has be-
come sensitized to chromium. He recommended modify-
ing the patch test to deliver the challenge dose by
iontophoresis. This would allow administration of the
dose in a short time period (approximately 30 min) and
would allow administration of a precisely regulated
challenge dose, allowing much more accurate quantifi-
cation than a passive diffusion patch test.
Bagdon noted that we really do not know about the
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effective dose. People arie patch tested for several hours
with chromium in petrolatum and water, and the pres-
ence ofthe lipid may not be a perfect model for environ-
mental dermal exposure. Since we really do not know
what we would see with 1000 ppm hexavalent chromium,
it is important to approach the problem using the patch
titration method that he described earlier. Where 0.5%
down to 0.001% is used, we would expect to see a gen-
eral decrease in susceptibility to the decreasing doses.
The traditional patch test is most useful in confirming a
clinical diagnosis, which is quite different from using it
as a prognostic indicator in a population or an individual
to determine whether at some time in the future a full
blown clinical dermatitis will occur.
Adams cautioned, however, that standcardization of a
technique is crucial and that any new approaches should
be validlated by running them in tandem with a standard
patch test. "It's the best test we have, and it's the only
test we have." He noted that he began testing for chro-
mium in about 1965 when the North American Contact
Dermatitis group was established. The use of a 0.5%/c
chromate solution, the same concentration used in the
first test in 1925, continued until about 1988, when the
concentration was reduced by consensus to 0.25%.
However, in Europe, patch testing for chromium sensi-
tivity is still done with a 0.5% solution, and the appiro-
priate dose remains a matter ofdebate. Adams indicated
that at 0.25% one will miss cases ofchromium sensitivity.
Selection of Appropriate Doses
A question was raised regarding patch testing with a
more realistic dose, such as 0.1% o0r 0.05%, which riepire-
sents the concentrations present in some of the soil at
contaminated sites rather than the industrial concen-
trations. R. Corcory noted, however, that there are
places in Hudson County, New Jersey, where the soil
concentration is actually as high as 1 to 4% at the soil
surface where people are working or children are play-
ing. There is often abrasion or other interruption of
skin integrity so that the opportunity for chromium
sensitization appears very real.
Adams also objected to the use of much lower doses,
noting that even at the present 0.25% concentration we
are likely to miss some allergy, although there is some
benefit from reduced irritation. Most people who are
going to respond will be sensitive between 0.1% and
0.25%, and that is what you want to reach.
Bagdon described the existing dose-response infor-
mation based on the patch titration studies of various
concentrations. At 0.01% concentration the proportion
of positive reactions was 13%. This increased to 26%
with a 0.05% concentration and 40% with a 0.1% con-
centration, while with 0.001% the response rate is about
1 to 3%. He speculated that if you used a 0.001% patch
test on a population of 100 people who were already
sensitized to chromium and had adiagnosis ofdermatitis,
you would get about 10% reactors, then the correspond-
ing threshold concentration would be 0.001%. It would
be important to know how this relate(d to concentra-
tions in soil.
R. Hazen noted that it is difficult to compare concen-
trations in soil to concentrations in solution. It is essen-
tial to undeerstand how much of the material is available
to react in the skin to elicit the allergic reaction. He noted
that analytic data suggest that much of the hexavalent
chromium would be available to reach the skin.
Relevance of Patch Testing to
Dermal Sensitization
Albert noted that two points were being confused.
The focus should not be on the odds ofa person with no
dcermatitis showing up with a positive patch test, but
on the irisk ofan exposed person developing dermatitis.
For example, what is the risk to a little child playing in
soils with concentrations above 1000 ppm ofdeveloping
chromium dermatitis?
Bagdon and Adams concurred that at present we do
not know the risk ofsensitization, but it is certainly not
negligible. We know somewhat more about the dose-
response curve for people who are already sensitized.
Gochfeld concluded that there appear to be two dif-
ferent dose-response issues, the traditional one of the
response of sensitized individuals to different concen-
trations or exposure levels of chromium and the re-
sponse curve for a normal population becoming sensi-
tized in the first place. The sensitization dose-response
curve is likely to look very different frtom the dermatitis
dose-response curve in sensitized people, which again
will be different firom the dermatitis dose-response curve
in population whose sensitization status is not known.
Bagdon noted that there is some evidence regarding
dose-response curves. For example, once sensitized, less
than 10%"lc of people respond to a 0.001% challenge, and
this seems to be consistent across occupational studies.
Process of Sensitization
Chromium sensitivity is a type IV delayed hypersen-
sitivity. The reaction is stimulated by haptens, which
have a molecular weight usually less than 500 and which
must combine with protein in the skin to stimulate the
development ofthe sensitized lymphocytes.
Gochfeld asked Adams if the general public in their
daily lives were exposed to dermal application of chro-
mium, would he anticipate a substantial number becom-
ing sensitized. Adams responded, "We really don't know.
One of the big problems with chromium is that humans
who are already sensitized respond at a very low level.
We're not absolutely certain about the total in the
population that cQuld be made sensitive." He added that
in the U.S., chromium exposure is almost exclusively
occupational, although in Europe it is thought to be
present in some detergents and that may be why in
nonoccupational populations chromium dermatitis is
more common in women.
He offered as an example that about 9% ofthe women
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in this country are probably allergic to nickel from ear
piercing. The pierced ear provides a route of access for
the nickel in the earring to sensitize the skin. He com-
pared this frequency with about the 70% ofthe popula-
tion that is reactive to poison ivy (Rhus dermatitis).
P. Lioy noted that even if there is a very low rate of
positive responses on patch tests, the risk of becoming
sensitized and subsequently developing dermatitis may
be high ifmany people are exposed to a large amount of
material. In other words, from a public health perspec-
tive it is just as important to be concerned with the
absolute magnitude of the risk (number of people be-
coming ill) as with the relative risk. He believed that
studying the dermal exposure and sensitization issue
should be given high priority.
Are Children at Increased Risk of
Sensitization or Dermatitis?
Where children are involved it is essential to know
whether they have increased likelihood of becoming
sensitized to contact allergens. Children's skin is differ-
ent from adult skin, and of course, their play behavior
increases their dermal exposure. Gochfeld noted that
up until about age 2, infants are believed to be at greater
risk ofsensitization to ingested antigens. Bagdon noted
that young animals are also more readily sensitized than
adults. Clearly, it is necessary to determine the extent
to which children are more readily sensitized than adults,
and Adams added, "Is the question whether they are
more readily sensitized, or once sensitized whether they
respond at a lower dose" and concluded, "I don't know
the answer to that."
A speaker suggested that children living in Jersey
City are exposed like a worker, but they live there all
day long, hence, sensitivity in the community study
needs to be handled differently from a traditional clinical
study or industrial cohort. Gochfeld remarked that
not only is a 168 hr/week exposure different from a 40-
hr exposure, but the latter allows some time for rea-
daptation and reduction ofexposure, hence the commu-
nity exposure is more than four times greater than
workplace exposure.
Sensitization to Hexavalent and
Trivalent Chromium
Adams noted that with poison ivy exposure the pure
pentadecyl catechol is a very effective sensitizer. By
contrast, hexavalent chromium is present at very low
levels, so its sensitization potential at different doses
would have to be explored. Also, trivalent chromium is
not a good sensitizer. For a clinician it seems important
to know how much hexavalent chromium is present in
the soil and whether that is enough to sensitize indi-
viduals who have not been sensitized before. We know
that many people who work with higher concentrations
of chromium, for example, in electroplating or cement
work, do not develop sensitization or at least do not
manifest contact dermatitis.
Lioy emphasized that this could be due to a self-selec-
tion process in the workplace. If you become ill you do
not continue working but switch jobs. This option is not
available if you live in a community where chromium
exposure occurs.
Risk Factors of Sensitization
B. Gerwel explored the issue of risk factors influenc-
ing a person's ability to be sensitized. Adams noted that
no one is born with sensitivity to chromium. It is devel-
oped and this has to do with many factors, for example,
whether or not there is irritation of the skin to start
with and what the concentration is. Chromium sensitiv-
ity is the number one sensitivity in cement workers,
but they seem to develop it after many weeks or even
years of irritation, which allows the chromium to get
into the skin and produce the allergic reaction.
The panel concurred that whatever information we
have on sensitization has to do with the environmental
components, such as methodology, vehicle, concentra-
tion, and irritation, and not with a person's underlying
genetic or epigenetic susceptibility to chromium or any
other contact allergens. Gochfeld riemarked that in gen-
eral our understanding of variation in human suscepti-
bility to any agent is meager.
Reactivity of Sensitized Individuals
A question was raised over which was more important,
the absolute mass ofmaterial contacting the skin or the
concentration. The panel concurred that since the mate-
rial is not absorbed into the body, concentration is
probably more important in determining reactiveness.
Thus, a 2-gg dose spread over a wide area will not have
the same effect as 2 ig administered under a patch.
Adams noted that patch test riesults can vary depending
on the vehicle, pH, or matrix used. Other variables are
how long the patch is in place (24-48 hr), how long after
removal of the patch one reads the reaction, and the
expertise ofthe reader.
Adams noted that there are only very limited data
for comparing response to absolute mass in skin, so from
a clinical point ofview (e.g., surveillance ofa population),
concentration is the critical thing. With respect to con-
centration in soil, "I doubt that we have the data to be
able to extrapolate from a soil matrix to a population."
The follow-up question was what happens ifexposure
occurs over a large area of the body, so that the mass
contacted is high. Again, whether a particular area of
the body responds depends on the dose reaching it,
which is a function ofthe concentration.
Is There Epidemiologic Evidence of
Elevated Dermatitis?
Bidstrup asked whether there is any evidence that
there is a high incidence of contact dermatitis in this
part of New Jersey, and Gochfeld remarked that more
research is needed on this topic. If one were dealing
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with mortality or with reportable (liseases such as can-
cer, these (lata would be available, and in(leedl one coul(l
compare events on a township-by-township basis. How-
ever, there is no (lata base for de(ematitis. One would
have to (levelop a surveillance system, contacting phy-
sicians who might see such patients. Since mild contact
(lermatitis (loes not necessitate a visit to a (lermatolo-
gist, one wroul(l have to use a broa(l net to pull in the
cases and thereby (letermine whether there is an excess
in northern New Jersey.
Is a Generic Approach to Chromium
Risk Possible?
One paiticipant inferred that given the com-plexities
both in the environment and the bodly, it appears to be
necessary to study exposure on every chromium site
that exists. Gochfeldl interprete(l this as a challenge to
the group, that is "to what extent can our science have
a predictive element. Can we develop generic principles
such that we (1o not have to study every new site de novo
as a unique entity? Perhaps it is not possible to develop
a generic approach. In that case science is not contrib-
uting the way it should be."
The panel concurreed that carefully controlled testing
by experienced investigators would be necessary to de-
termine the extent to which a particular population has
alreadly been sensitized as well as the dose-response
curve for sensitized indlivi(luals. One problem is whether
the testing itself carriies with it a finite risk of sensitiz-
ing indivi(luals.
Overall, the panel session i(lentified a) the need to
improve our' un(lerstanding of bioavailability, both for
toxicologic studies an(l for human exposure studies; b)
the need to improve our understanding of human sus-
ceptibility to chromium sensitization; and c) the nee(d to
establish dose-r-esponse curves both for initial sensitiza-
tion an(l for (lermal reactivity ofsensitized individuals.
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